William A. Haseltine

Insider Reports History

SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Jason Comerford, attorney-in fact for Mr.Haseltine
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for William A. Haseltine

Form 4 holding Director

Acasti Pharma Inc.

Security class
Stock Options (Right to Buy)
Shares / value
42,100
Estimated value
Report date
12 Nov 2021
Price
Ownership
Direct
Underlying class
Class A Common Shares
Underlying amount

Insider Reports Filed by William A. Haseltine

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .